The value of cardiopulmonary exercise testing and brain natriuretic peptide plasma levels in predicting the prognosis of patients with chronic heart failure

European Journal of Internal Medicine

Volumn 17, Issue 2, 2006, Pages 96-101

  Krüger, Stefan ^a,b   Graf, Jürgen ^a   Merx, Marc W ^a   Stickel, Tina ^a   Kunz, Dagmar ^a   Koch, Karl Christian ^a   Hanrath, Peter ^a   Janssens, Uwe ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Brain natriuretic peptide; Chronic heart failure; Exercise testing; Prognosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PEPTIDE ANALYSIS; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

EID: 33144478756     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2005.11.001     Document Type: Article

References (30)

1. SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction N Engl J Med 327 1992 685 691
2. P.J. Cowburn, J.G. Cleland, A.J. Coats, and M. Komajda Risk stratification in chronic heart failure Eur Heart J 19 1998 696 710
3. M.R. Costanzo, S. Augustine, R. Bourge, M. Bristow, J.B. O'Connell, and D. Driscoll Selection and treatment of candidates for heart transplantation Circulation 92 1995 3593 3612
4. J. Myers, L. Gullestad, R. Vagelos, D. Do, D. Bellin, and H. Ross Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure Ann Intern Med 129 1998 286 293
5. D.M. Mancini, H. Eisen, W. Kussmaul, R. Mull, L.H. Edmunds Jr., and J.R. Wilson Value of peak exercise consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure Circulation 83 1991 778 786
6. C. Opasich, G.D. Pinna, M. Bobbio, M. Sisti, B. Demichelis, and O. Febo Peak exercise oxygen consumption in chronic heart failure: toward efficient use in individual patient J Am Coll Cardiol 31 1998 766 775
7. R.W. Troughton, C.M. Frampton, T.G. Yandle, E.A. Espiner, M.G. Nicholls, and A.M. Richards Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126 1130
8. T. Tsutamoto, A. Wada, K. Maeda, T. Hisanaga, N. Mabuchi, and M. Hayashi Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1 Eur Heart J 20 1999 1799 1807
9. T. Tsutamoto, A. Wada, and K. Maeda Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96 1997 509 516
10. V. Cheng, R. Kazanagra, and A. Garcia A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study J Am Coll Cardiol 37 2001 386 391
11. Q. Dao, P. Krishnaswamy, and R. Kazanagra Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent care setting J Am Coll Cardiol 37 2001 379 385
12. P.A. McCullough, R.M. Nowak, J. McCord, J.E. Hollander, H.C. Herrmann, and P.G. Steg B-type natriuretic peptide and clinical judgement in emergency diagnosis of heart failure. Analysis from Breathing Not Properly (BNP) Multinational Study Circulation 106 2002 416 422
13. J. Koglin, S. Pehlivanli, M. Schwaiblmair, M. Vogeser, P. Cremer, and W. von Scheidt Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure J Am Coll Cardiol 38 2001 1934 1941
14. S.A. Hunt, D.W. Baker, M.H. Chin, M.P. Cinquegrani, A.M. Feldman, and G.S. Francis ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult Circulation 104 2001 2996 3007
15. P. Ponikowski, D.P. Francis, M.F. Piepoli, L.C. Davies, T.P. Chua, and C.H. Davos Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis Circulation 103 2001 967 972
16. K. Pardaens, J. Van Cleemput, J. Vanhaecke, and R.H. Fagard Peak oxygen uptake better predicts outcome than submaximal respiratory data in heart transplant candidates Circulation 101 2000 1152 1157
17. 2. A simple yet enduring standard Circulation 101 2000 1080 1082
18. S. Krüger, J. Graf, D. Kunz, T. Stickel, P. Hanrath, and U. Janssens Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure J Am Coll Cardiol 40 2002 718 722
19. M. Mc Nairy, N. Gardetto, P. Clopton, A. Garcia, P. Krishnaswamy, and R. Kazanegra Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: implications for outpatient monitoring with B-type natriuretic peptide Am Heart J 143 2002 406 411
20. S. Krüger, J. Graf, M.W. Merx, T. Stickel, D. Kunz, and P. Hanrath Brain natriuretic peptide kinetics during dynamic exercise in patients with chronic heart failure Int J Cardiol 95 2004 49 54
21. R. Berger, M. Huelsman, K. Strecker, A. Bojic, P. Moser, and B. Stanek B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 2002 2392 2397
22. R. Isnard, F. Pousset, O. Chafirovskaia, A. Carayon, J.S. Hulot, and D. Thomas Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure Am Heart J 146 2003 729 735
23. R.S. Gardner, F. Ozalp, A.J. Murday, S.D. Robb, and T.A. McDonagh N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure Eur Heart J 24 2003 1735 1743
24. S.S. Gottlieb, M.L. Kukin, D. Ahern, and M. Packer Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure J Am Coll Cardiol 13 1989 1534 1539
25. M. Hülsmann, B. Stanek, B. Frey, B. Sturm, D. Putz, and T. Kos Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure J Am Coll Cardiol 32 1998 1695 1700
26. F. Pousset, R. Isnard, and P. Lechat Prognostic value of plasma endothelin-1 in patients with chronic heart failure Eur Heart J 18 1997 254 258
27. J. Cohn, B. Levine, M. Olivari, V. Garberg, D. Lura, and G.S. Francis Plasma norepinephrine as a guide to prognosis in patients with chronic heart failure N Engl J Med 311 1984 819 823
28. K. Kawai, K. Hata, H. Takaoka, H. Kawai, and M. Yokoyama Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during β-blocker therapy: a potential of hormone-guided treatment Am Heart J 141 2001 925 932
29. S. Talwar, I.B. Squire, P.F. Downie, A.M. Mccullough, M.C. Campton, and J.E. Davies Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction Eur Heart J 21 2000 1514 1521
30. T. Tsutamoto, A. Wada, K. Maeda, T. Hisanaga, D. Fukai, and Y. Maeda Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure Am Heart J 134 1997 910 916